NAMSA Market Share Analysis for April 2026

NAMSA is a world authority in medical device and IVD preclinical/clinical research, biological safety testing and regulatory compliance.

Health > Health - Other

Domainnamsa.com

Year Founded1967

Employees1001 - 5000

Annual Revenue$200M - $500M

NAMSA

NAMSA (including company regionals)

namsa.com

See more website traffic and engagement information

NAMSA Revenue up to April 2026 is 200M - 500M

revenue generated by NAMSA top domains

NAMSA top domains revenue over 3 years

Revenue for NAMSA top domains

namsa.com200M - 500M

See more with Sales Intelligence

Total visits to NAMSA's top domains

Understand NAMSA market share and potential market reach.

Total visits last 3 months

Subsidiaries Breakdown

namsa.com60.2K

See more with Sales Intelligence

Avg. visit duration in NAMSA's top domains

Analyze NAMSA engagement metrics.

Average visit duration last 3 months

Subsidiaries Breakdown

namsa.com00:00:59

See more with Sales Intelligence

Avg. pageviews on NAMSA's top domains

See how NAMSA keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

Subsidiaries Breakdown

namsa.com1.68

See more with Sales Intelligence

NAMSA top competitors by domain

Top similar sites in April 2026, ranked by their affinity

nelsonlabs.comCompany NameNelson LabsEmployees501 - 1000HQUnited States, Utah, Salt Lake CityAnnual revenue$100M - $200MTotal visits39.9KScience and Education > Biology

Top technologies used by NAMSA

These are the website technologies, by industry, used by NAMSA top domains

Payment & Currencies (18)

Cart Functionality

Widget (6)

Twemoji

Conversion & Analytics (5)

Google Analytics

Content Management System (4)

WordPress

More Technologies

11

See all

News & Signals from NAMSA

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsNamsa, Llc partnered with Lexitas Pharma Services Inc. on Apr 30th '26.TOLEDO, Ohio and DURHAM, N.C., April 30, 2026 /PRNewswire/ - NAMSA, the global leader in MedTech contract research offering end-to-end development services, today announced a strategic partnership with Lexitas Pharma Services, the leading full-service ophthalmology contract research organization (CRO), to deliver comprehensive product development support to ophthalmic medical device sponsors.

NewsNamsa, Llc hired Scott Day as Vice President, Clinical and Consulting Business Development on Apr 20th '26.TOLEDO, Ohio, April 20, 2026 /PRNewswire/ - NAMSA, the global leader in MedTech contract research offering end-to-end development services from clinical research and regulatory-commercial consulting to biocompatibility testing and preclinical solutions, today announced the appointment of Scott Day as Vice President, Clinical and Consulting Business Development, effective April 20, 2026.

NewsNamsa, Llc hires Brian P. Smith as Chief Executive Officer.Brian P. Smith joins NAMSA as Chief Executive Officer; brings 15+ years of life sciences leadership expertise to role.